Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline

被引：326

作者：

Hershberger, Ray E. ^{[1
]}

Lindenfeld, Joann ^{[2
]}

Mestroni, Luisa ^{[2
,3
]}

Seidman, Christine E. ^{[4
,5
]}

Taylor, Matthew R. G. ^{[2
,3
]}

Towbin, Jeffrey A. ^{[6
]}

机构：

[1] Univ Miami, Sch Med, Div Cardiovasc, Miami, FL 33101 USA

[2] Univ Colorado, Hlth Sci Ctr, Div Cardiol, Denver, CO 80262 USA

[3] Univ Colorado, Hlth Sci Ctr, Adult Med Genet Program, Denver, CO 80262 USA

[4] Harvard Univ, Brigham & Womens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA

[5] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Genet Ctr, Boston, MA 02115 USA

[6] Baylor Coll Med, Div Pediat Cardiol, Houston, TX 77030 USA

来源：

JOURNAL OF CARDIAC FAILURE | 2009年 / 15卷 / 02期

关键词：

RIGHT-VENTRICULAR CARDIOMYOPATHY; LAMIN-A/C GENE; MYOSIN HEAVY-CHAIN; CARDIAC TROPONIN-I; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; X-LINKED GENE; DILATED CARDIOMYOPATHY; CONDUCTION-SYSTEM; ACTIN GENE; MUTATIONAL ANALYSIS;

D O I：

10.1016/j.cardfail.2009.01.006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Substantial progress has been made recently in understanding the genetic basis of cardiomyopathy. Cardiomyopathies with known genetic cause include hypertrophic (HCM), dilated (DCM), restrictive (RCM), arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) and left ventricular noncompaction (LVNC). HCM, DCM, and RCM have been recognized as distinct clinical entities for decades, whereas ARVD/C and LVNC are relative newcomers to the field. Hence the clinical and genetic knowledge for each cardiomyopathy varies, as do the recommendations and strength of evidence. (J Cardiac Fail 2009;15:83-97)

引用

页码：83 / 97

页数：15

共 111 条

[1] Executive summary:: HFSA 2006 comprehensive heart failure practice guideline
Adams, KF
Lindenfeld, J
Arnold, JMO
Baker, DW
Barnard, DH
Baughman, KL
Boehmer, JP
Deedwania, P
Dunbar, SB
Elkayam, U
Gheorghiade, M
Howlett, JG
Konstam, MA
Kronenberg, MW
Massie, BM
Mehra, MR
Miller, AB
Moser, DK
Patterson, JH
Rodeheffer, RJ
Sackner-Bernstein, J
Silver, MA
Starling, RC
Stevenson, LW
Wagoner, LE
Francis, GS
Bristow, MR
Cohn, JN
Colucci, WS
Greenberg, BH
Force, T
Krumholz, HM
Liu, PP
Mann, DL
Piña, IL
Pressler, SJ
Sabbah, HN
Yancy, CW
[J]. JOURNAL OF CARDIAC FAILURE, 2006, 12 (01) : 10 - 38
[2] Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis
Antoniades, Loizos
Tsatsopoulou, Adalena
Anastasakis, Aris
Syrris, Petros
Asimaki, Angeliki
Panagiotakos, Demosthenes
Zambartas, Costas
Stefanadis, Christodoulos
McKenna, William J.
Protonotarios, Nikos
[J]. EUROPEAN HEART JOURNAL, 2006, 27 (18) : 2208 - 2216
[3] Glycogen storage diseases presenting as hypertrophic cardiomyopathy
Arad, M
Maron, BJ
Gorham, JM
Johnson, WH
Saul, JP
Perez-Atayde, AR
Spirito, P
Wright, GB
Kanter, RJ
Seidman, CE
Seidman, JG
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (04) : 362 - 372
[4] Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy
Arad, M
Benson, DW
Perez-Atayde, AR
McKenna, WJ
Sparks, EA
Kanter, RJ
McGarry, K
Seidman, JG
Seidman, CE
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (03) : 357 - 362
[5] Autosomal dominant dilated cardiomyopathy with atrioventricular block: A lamin A/C defect-related disease
Arbustini, E
Pilotto, A
Repetto, A
Grasso, M
Negri, A
Diegoli, M
Campana, C
Scelsi, L
Baldini, E
Gavazzi, A
Tavazzi, L
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (06) : 981 - 990
[6] DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy
Awad, Mark M.
Dalal, Darshan
Cho, Eunpi
Amat-Alarcon, Nuria
James, Cynthia
Tichnell, Crystal
Tucker, April
Russell, Stuart D.
Bluemke, David A.
Dietz, Harry C.
Calkins, Hugh
Judge, Daniel P.
[J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2006, 79 (01) : 136 - 142
[7] High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation
Bécane, HM
Bonne, G
Varnous, S
Muchir, A
Ortega, V
Hammouda, E
Urtizberea, JA
Lavergne, T
Fardeau, M
Eymard, B
Weber, S
Schwartz, K
Duboc, D
[J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2000, 23 (11): : 1661 - 1666
[8] Regulatory mutations in transforming growth factor-β3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1
Beffagna, G
Occhi, G
Nava, A
Vitiello, L
Ditadi, A
Basso, C
Bauce, B
Carraro, G
Thiene, G
Towbin, JA
Danieli, GA
Rampazzo, A
[J]. CARDIOVASCULAR RESEARCH, 2005, 65 (02) : 366 - 373
[9] Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors
Berg, Alfred O.
Piper, Margaret
Armstrong, Katrina
Botkin, Jeffrey
Calonge, Ned
Haddow, James
Hayes, Maxine
Kaye, Celia
Phillips, Kathryn A.
Richards, Carolyn Sue
Scott, Joan A.
Strickland, Ora L.
Teutsch, Steven
[J]. GENETICS IN MEDICINE, 2007, 9 (12) : 819 - 825
[10] ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating
Bienengraeber, M
Olson, TM
Selivanov, VA
Kathmann, EC
O'Cochlain, F
Gao, F
Karger, AB
Ballew, JD
Hodgson, DM
Zingman, LV
Pang, YP
Alekseev, AE
Terzic, A
[J]. NATURE GENETICS, 2004, 36 (04) : 382 - 387

← 1 2 3 4 5 6 7 8 9 10 →